Tumor-derived exosomes: unravelling the pathogenesis of pancreatic cancer with liver metastases and exploring the potential for clinical translation
Cancer Letters,
Journal Year:
2024,
Volume and Issue:
611, P. 217403 - 217403
Published: Dec. 19, 2024
Language: Английский
The role of macrophages in liver metastasis: mechanisms and therapeutic prospects
Qin Yuan,
No information about this author
Linlin Jia,
No information about this author
Jiahua Yang
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 17, 2025
Metastasis
is
a
hallmark
of
advanced
cancer,
and
the
liver
common
site
for
secondary
metastasis
many
tumor
cells,
including
colorectal,
pancreatic,
gastric,
prostate
cancers.
Macrophages
in
microenvironment
(TME)
promote
cell
through
various
mechanisms,
angiogenesis
immunosuppression,
play
unique
role
development
metastasis.
are
affected
by
variety
factors.
Under
conditions
hypoxia
increased
acidity
TME,
more
factors
now
found
to
polarization
macrophages
M2
type,
exosomes
amino
acids.
M2-type
secretion
such
as
VEGF,
IL-1β,
TGF-β1.
subjected
multiple
regulatory
mechanisms.
They
also
interact
with
cells
within
co-regulate
certain
conditions,
creation
an
immunosuppressive
microenvironment.
This
interaction
promotes
metastasis,
drug
resistance,
immune
escape.
Based
on
advent
single-cell
sequencing
technology,
further
insights
into
macrophage
subpopulations
may
help
exploring
new
therapeutic
targets
future.
In
this
paper,
we
will
focus
how
affect
well
other
each
other,
investigate
mechanisms
involved
their
potential
targets.
Language: Английский
Multiple roles of mitochondria in tumorigenesis and treatment: from mechanistic insights to emerging therapeutic strategies
ONCOLOGIE,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 17, 2025
Language: Английский
Oleanolic acid inhibits M2 macrophage polarization and potentiates anti-PD-1 therapy in hepatocellular carcinoma by targeting miR-130b-3p-PTEN-PI3K-AKT signaling and glycolysis
Xiaoyu Tu,
No information about this author
Wanfu Lin,
No information about this author
Xiaofeng Zhai
No information about this author
et al.
Phytomedicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 156750 - 156750
Published: April 1, 2025
Language: Английский
microRNA-4488 is differentially regulated during dengue virus infection and clearance of the virus
Roxana Filip,
No information about this author
Parrish Evers,
No information about this author
Spencer M. Uguccioni
No information about this author
et al.
Frontiers in RNA Research,
Journal Year:
2025,
Volume and Issue:
3
Published: April 16, 2025
Dengue
virus
(DENV)
is
a
zoonotic
disease
transmitted
to
humans
via
mosquito
bites.
Viral
infection
systemic
in
and
can
lead
organ
failure
including
the
liver.
Since
there
are
many
molecular
changes
that
precede
liver
failure,
identification
of
progress
at
level
informative.
As
an
RNA
virus,
DENV
perturbs
non-coding
RNAs
microRNAs.
Here
we
examine
microRNA
profiles
hepatoma
cells
using
small
molecule–mediated
annotation
miRNA
targets.
It
was
previously
shown
treatment
with
broadly
antiviral
oxysterol
25-hydroxycholesterol
(25HC)
induces
expression
microRNAs
Herein,
show
25HC
potently
against
identify
miR-4488
as
which
overexpressed
during
downregulated
treatment.
We
also
when
viral
levels
lowered
siRNA,
suggesting
this
involved
host-response
infection.
closely
correlate
liver,
it
serves
biomarker
for
may
contribute
overall
effects
organ.
Language: Английский
A review of the role of tumor-derived exosomes in cancers treatment and progression
Wajida Ataallah Khidr,
No information about this author
Karar H. Alfarttoosi,
No information about this author
Waam Mohammed Taher
No information about this author
et al.
International Immunopharmacology,
Journal Year:
2025,
Volume and Issue:
157, P. 114782 - 114782
Published: May 6, 2025
Language: Английский
Progress of exosomes in regulating tumor metastasis by remodeling the pre-metastatic immune microenvironment
Jiangning Xiang,
No information about this author
Yao Lin,
No information about this author
Shan Wang
No information about this author
et al.
Cellular Immunology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 104960 - 104960
Published: May 1, 2025
Language: Английский
Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy
Journal of Experimental & Clinical Cancer Research,
Journal Year:
2025,
Volume and Issue:
44(1)
Published: May 16, 2025
Despite
the
significant
advances
in
development
of
immune
checkpoint
inhibitors
(ICI),
primary
and
acquired
ICI
resistance
remains
impediment
to
effective
cancer
immunotherapy.
Residing
tumor
microenvironment
(TME),
tumor-associated
macrophages
(TAMs)
play
a
pivotal
role
progression
by
regulating
diverse
signaling
pathways.
Notably,
accumulating
evidence
has
confirmed
that
TAMs
interplay
with
various
cellular
components
within
TME
directly
or
indirectly
maintain
dynamic
balance
M1/M2
ratio
shape
an
immunosuppressive
TME,
consequently
conferring
evasion
immunotherapy
tolerance.
Detailed
investigation
communication
network
around
could
provide
potential
molecular
targets
optimize
therapies.
In
this
review,
we
systematically
summarize
latest
understanding
origin
functional
plasticity
TAMs,
focus
on
key
pathways
driving
macrophage
polarization
stimuli
regulate
process.
Moreover,
elaborate
intricate
between
other
constituents
is
initiation,
evasion,
exploring
novel
for
We
further
discuss
current
challenges
future
research
directions,
emphasizing
need
decode
TAM-TME
interactions
translate
preclinical
findings
into
clinical
breakthroughs.
conclusion,
while
TAM-targeted
therapies
hold
promise
enhancing
outcomes,
addressing
challenges-such
as
TAM
heterogeneity,
context-dependent
plasticity,
therapeutic
resistance-remains
critical
achieving
optimal
efficacy.
Language: Английский
Immunosuppressive tumor microenvironment in pancreatic cancer: mechanisms and therapeutic targets
Da Pan,
No information about this author
Xinyue Li,
No information about this author
Xiao Qiao
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: May 15, 2025
Pancreatic
cancer
is
projected
to
become
the
second
leading
cause
of
cancer-related
death
by
2030.
Conventional
interventions
including
surgery,
radiotherapy,
and
chemotherapy
provide
only
modest
survival
benefits,
underscoring
an
urgent
need
for
more
effective
therapies.
Although
immunotherapy
has
revolutionized
management
several
solid
tumors,
its
clinical
benefit
in
pancreatic
so
far
been
disappointing.
Mounting
evidence
indicates
that
a
highly
immunosuppressive
tumor
microenvironment
(TME),
dominated
tumor-associated
macrophages
(TAMs),
myeloid-derived
suppressor
cells
(MDSCs),
regulatory
T
(Tregs),
drives
immune
evasion,
progression,
metastasis,
chemoresistance
through
complex
cytokine
chemokine
networks.
This
review
summarizes
current
knowledge
these
mechanisms
provides
emerging
strategies
aimed
at
re-educating
or
depleting
cellular
constituents
enhance
efficacy
cancer.
Language: Английский
Unraveling the advances of non-coding RNAs on the tumor microenvironment: innovative strategies for cancer therapies
Di Mu,
No information about this author
Bing Han,
No information about this author
Yi Luo
No information about this author
et al.
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: June 2, 2025
Non-coding
RNAs
(ncRNAs)
are
crucial
molecules
that
do
not
encode
proteins
but
play
roles
in
regulating
various
biological
processes.
Recent
research
highlights
ncRNAs
only
control
gene
expression
within
cells
also
facilitate
intercellular
communication
via
exosomes
and
other
carriers.
This
function
is
vital
the
tumor
microenvironment
(TME).
Our
review
covers
structure
functions
of
different
ncRNAs,
such
as
microRNAs
(miRNAs),
long
non-coding
(lncRNAs),
circular
(circRNAs).
We
examine
how
these
influence
initiation
progression.
Additionally,
we
explore
their
role
promoting
growth
or
immune
evasion
by
modulating
TME.
The
potential
using
therapeutic
targets
biomarkers
for
clinical
use
discussed.
As
our
understanding
grows,
development
new
therapies
based
on
anticipated
to
offer
improved
treatment
options
cancer
patients.
Language: Английский